Rasagiline, an inhibitor of MAO ‐B, decreases colonic motility through elevating colonic dopamine content

Neurogastroenterology&Motility, EarlyView.

Source: Neurogastroenterology and Motility - June 29, 2018 Category: Gastroenterology Authors: C. ‐Z. Liu , X.‐L. Zhang , L. Zhou , T. Wang , Z.‐S. Quan , Y. Zhang , J. Li , G.‐W. Li , L.‐F. Zheng , L.‐S. Li , J.‐X. Zhu Source Type: research